264 related articles for article (PubMed ID: 38343065)
1. Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
Vagnildhaug OM; Balstad TR; Ottestad I; Bye A; Greil C; Arends J; Baracos V; Brown LR; Dajani OF; Dolan RD; Fallon M; Fraser E; Grzyb A; Hjermstad MJ; Jakobsen G; Kaasa S; McDonald J; Philips I; Sayers J; Simpson MR; Sousa MS; Skipworth RJE; Laird BJA; Solheim TS;
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):513-535. PubMed ID: 38343065
[TBL] [Abstract][Full Text] [Related]
2. Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series.
Hjermstad MJ; Jakobsen G; Arends J; Balstad TR; Brown LR; Bye A; Coats AJS; Dajani OF; Dolan RD; Fallon MT; Greil C; Grzyb A; Kaasa S; Koteng LH; May AM; McDonald J; Ottestad I; Philips I; Roeland EJ; Sayers J; Simpson MR; Skipworth RJE; Solheim TS; Sousa MS; Vagnildhaug OM; Laird BJA;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):794-815. PubMed ID: 38553255
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
McDonald J; Sayers J; Anker SD; Arends J; Balstad TR; Baracos V; Brown L; Bye A; Dajani O; Dolan R; Fallon MT; Fraser E; Griel C; Grzyb A; Hjermstad M; Jamal-Hanjani M; Jakobsen G; Kaasa S; McMillan D; Maddocks M; Philips I; Ottestad IO; Reid KF; Sousa MS; Simpson MR; Vagnildhaug OM; Skipworth RJE; Solheim TS; Laird BJA;
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):1932-1948. PubMed ID: 37671529
[TBL] [Abstract][Full Text] [Related]
5. Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series.
Brown LR; Sousa MS; Yule MS; Baracos VE; McMillan DC; Arends J; Balstad TR; Bye A; Dajani O; Dolan RD; Fallon MT; Greil C; Hjermstad MJ; Jakobsen G; Maddocks M; McDonald J; Ottestad IO; Phillips I; Sayers J; Simpson MR; Vagnildhaug OM; Solheim TS; Laird BJA; Skipworth RJE;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):816-852. PubMed ID: 38738581
[TBL] [Abstract][Full Text] [Related]
6. Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series.
Yule MS; Thompson J; Leesahatsawat K; Sousa MS; Anker SD; Arends J; Balstad TR; Brown LR; Bye A; Dajani O; Fallon M; Hjermstad MJ; Jakobsen G; McDonald J; McGovern J; Roeland EJ; Sayers J; Skipworth RJE; Ottestad IO; Philips I; Simpson MR; Solheim TS; Vagnildhaug OM; McMillan D; Laird BJA; Dolan RD;
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):853-867. PubMed ID: 38783477
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.
Bland KA; Harrison M; Zopf EM; Sousa MS; Currow DC; Ely M; Agar M; Butcher BE; Vaughan V; Dowd A; Martin P
J Pain Symptom Manage; 2021 Sep; 62(3):e164-e176. PubMed ID: 33652095
[TBL] [Abstract][Full Text] [Related]
8. Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod? - analysis from a multicenter cross sectional study.
Solheim TS; Blum D; Fayers PM; Hjermstad MJ; Stene GB; Strasser F; Kaasa S
Acta Oncol; 2014 Apr; 53(4):539-46. PubMed ID: 23998647
[TBL] [Abstract][Full Text] [Related]
9. Exercise for cancer cachexia in adults.
Grande AJ; Silva V; Sawaris Neto L; Teixeira Basmage JP; Peccin MS; Maddocks M
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010804. PubMed ID: 33735441
[TBL] [Abstract][Full Text] [Related]
10. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
11. Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?
Valaire R; Garden F; Razmovski-Naumovski V
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1146-1156. PubMed ID: 38533530
[TBL] [Abstract][Full Text] [Related]
12. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
13. Endpoints in clinical trials in cancer cachexia: where to start?
Laird BJA; Balstad TR; Solheim TS
Curr Opin Support Palliat Care; 2018 Dec; 12(4):445-452. PubMed ID: 30299325
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review.
Solheim TS; Fearon KC; Blum D; Kaasa S
Acta Oncol; 2013 Jan; 52(1):6-17. PubMed ID: 23020528
[TBL] [Abstract][Full Text] [Related]
15. Megestrol acetate for treatment of anorexia-cachexia syndrome.
Ruiz Garcia V; López-Briz E; Carbonell Sanchis R; Gonzalvez Perales JL; Bort-Marti S
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD004310. PubMed ID: 23543530
[TBL] [Abstract][Full Text] [Related]
16. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin for the management of cachexia associated with cancer.
Khatib MN; Shankar AH; Kirubakaran R; Gaidhane A; Gaidhane S; Simkhada P; Quazi Syed Z
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012229. PubMed ID: 29489032
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
19. Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors.
Morgan EH; Schoonees A; Sriram U; Faure M; Seguin-Fowler RA
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012547. PubMed ID: 31902132
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
